The proteolytic cleavage of protein kinase C isotypes, which generates kinase and regulatory fragments, correlates with Fas-mediated and 12-O-tetradecanoyl-phorbol-13-acetate-induced apoptosis.

Protein kinase C (PKC) has been implicated in signaling induced by diverse sets of stimuli regulating growth, differentiation, and apoptosis. The present study focused on the fate of PKC isotype proteins during Fas-mediated apoptosis of human leukemic cell lines. Among the PKC isotypes expressed in different cell types, such as Jurkat, HPB-ALL, U937, and HL60, all the nPKC isotypes including nPKCdelta, nPKC epsilon, and nPKCtheta, but not cPKC alpha and betaII and aPKCzeta (n, c, and a represent novel, conventional and atypical, respectively), showed limited proteolytic cleavage during Fas-mediated apoptosis. The limited proteolysis of nPKC isotypes means the disappearance of the intact protein band concomitant with the appearance of two fragments, most likely containing the kinase and regulatory domains, in contrast to the so-called down-regulation known for both cPKC and nPKC isotypes following exposure to stimuli such as 12-O-tetradecanoyl-phorbol 13-acetate (TPA). The time course of Fas-mediated apoptosis in Jurkat cells parallels that of the activation of a 32-kDa cysteine protease (CPP32)-like protease and also closely parallels the proteolytic cleavage of nPKC isotypes. A peptide inhibitor of the CPP32-like protease, Ac-DEVD-CHO, blocked the proteolytic cleavage of nPKC isotypes as well as apoptosis mediated by Fas. Transfection of recombinant protein coding for the catalytic fragment of nPKCdelta to COS1 cells resulted in the apoptotic morphology of cells and nuclei. The effect of TPA on apoptosis depends on the cell type. TPA significantly suppressed Fas-mediated apoptosis in Jurkat, whereas TPA alone caused apoptosis in HPB-ALL, U937, and HL60, only slight apoptosis in Jurkat. The proteolytic fragmentation of nPKC isotypes again closely correlated with the degree of apoptosis even in apoptosis induced by TPA. Separation of TPA-treated cells into apoptotic and non-apoptotic differentiating cells revealed that the proteolytic fragmentation of nPKC isotypes occurs only in apoptotic cells and, in adherent differentiating cells, nPKC isotypes as well as cPKC alpha were down-regulated without the generation of nPKC fragments. These results are consistent with the idea that nPKC isotypes meet two different fates, down-regulation and proteolytic cleavage generating kinase and regulatory fragments, and that the proteolytic cleavage of nPKC isotypes is a step in the signaling pathway involved in Fas-mediated and TPA-induced apoptosis.

[1]  M. Watabe,et al.  Activation of protein kinase C prevents induction of apoptosis by geranylgeraniol in human leukemia HL60 cells , 1997, International journal of cancer.

[2]  Xiaodong Wang,et al.  DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.

[3]  S. Ratnofsky,et al.  Proteolytic Activation of Protein Kinase C ␦ by an Ice/ced 3-like Protease Induces Characteristics of Apoptosis Materials and Methods , 1996 .

[4]  M. Whyte.  A link between cell-surface receptors and ICE proteases. , 1996, Trends in cell biology.

[5]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[6]  M. Diaz-Meco,et al.  The Product of par-4, a Gene Induced during Apoptosis, Interacts Selectively with the Atypical Isoforms of Protein Kinase C , 1996, Cell.

[7]  M. Whyte,et al.  ICE/CED-3 proteasesin apoptosis. , 1996, Trends in cell biology.

[8]  S. Spiegel,et al.  Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate , 1996, Nature.

[9]  G. Evan,et al.  A License to Kill , 1996, Cell.

[10]  Y. Tsujimoto,et al.  Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. , 1996, Cancer research.

[11]  J. Lazo,et al.  Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells. , 1996, Experimental cell research.

[12]  D. Kufe,et al.  Activation of protein kinase Cdelta in human myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine , 1996 .

[13]  Q. Dou,et al.  Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. , 1996, Cancer research.

[14]  S. Moriya,et al.  EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3‐kinase. , 1996, The EMBO journal.

[15]  R. Weichselbaum,et al.  Proteolytic activation of protein kinase C delta by an ICE‐like protease in apoptotic cells. , 1995, The EMBO journal.

[16]  D. Faller,et al.  Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. , 1995, Oncogene.

[17]  J. Chen,et al.  Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. Role for p53-independent induction of gadd-45 in initiating death. , 1995, The Journal of clinical investigation.

[18]  C. Young,et al.  Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells. , 1995, Biochemical and biophysical research communications.

[19]  J. de Vente,et al.  Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[20]  Seamus J. Martin,et al.  Proteolysis of Fodrin (Non-erythroid Spectrin) during Apoptosis (*) , 1995, The Journal of Biological Chemistry.

[21]  S. Grant,et al.  Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. , 1994, The Journal of biological chemistry.

[22]  S. Hirai,et al.  Specificity of the high affinity interaction of protein kinase C with a physiological substrate, myristoylated alanine-rich protein kinase C substrate. , 1994, The Journal of biological chemistry.

[23]  G. Meinhardt,et al.  Characterization of human TUR leukemia cells: continued cell cycle progression in the presence of phorbol ester is associated with resistance to apoptosis. , 1994, European journal of cell biology.

[24]  A. Altman,et al.  Expression and biochemical characterization of human protein kinase C-theta. , 1994, European journal of biochemistry.

[25]  Y. Lazebnik,et al.  Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE , 1994, Nature.

[26]  F. Uchiumi,et al.  Sodium benzylideneascorbate induces apoptosis in HIV‐replicating U1 cells , 1994, FEBS letters.

[27]  T. Shea,et al.  Degradation of protein kinase C alpha and its free catalytic subunit, protein kinase M, in intact human neuroblastoma cells and under cell-free conditions. Evidence that PKM is degraded by mM calpain-mediated proteolysis at a faster rate than PKC. , 1994, FEBS letters.

[28]  M. Clerici,et al.  Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. , 1994, Journal of immunology.

[29]  K. Suzuki,et al.  Activation of novel protein kinases C delta and C epsilon upon mitogenic stimulation of quiescent rat 3Y1 fibroblasts. , 1994, The Journal of biological chemistry.

[30]  A. Malkinson,et al.  Calpain activation in apoptosis , 1994, Journal of cellular physiology.

[31]  K. Suzuki,et al.  Ras‐dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKC delta. , 1994, The EMBO journal.

[32]  S. Grant,et al.  Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. , 1994, Cancer research.

[33]  S. Grant,et al.  Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. , 1994, Biochemical pharmacology.

[34]  V. Sánchez-Margalet,et al.  Protein kinase C activation promotes cell survival in mature lymphocytes prone to apoptosis. , 1994, Biochemical pharmacology.

[35]  S. L. Hyatt,et al.  Protein kinase C domains involved in interactions with other proteins. , 1994, Biochemistry.

[36]  L. Dekker,et al.  Protein kinase C--a question of specificity. , 1994, Trends in biochemical sciences.

[37]  C. M. Cohen,et al.  Phorbol 12-myristate 13-acetate-stimulated phosphorylation of erythrocyte membrane skeletal proteins is blocked by calpain inhibitors: possible role of protein kinase M. , 1993, The Biochemical journal.

[38]  P. Walker,et al.  Relationship between apoptosis and the cell cycle in lymphocytes: roles of protein kinase C, tyrosine phosphorylation, and AP1. , 1993, Experimental cell research.

[39]  A. Altman,et al.  Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. , 1993, The Journal of biological chemistry.

[40]  C. Turck,et al.  Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma cells. , 1993, Journal of immunology.

[41]  M. Maurer,et al.  Role of cofactors in protein kinase C activation. , 1992, Cellular signalling.

[42]  Y. Nishizuka.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[43]  T. Saitoh,et al.  The involvement of protein kinase C in activation-induced cell death in T-cell hybridoma. , 1992, Cellular immunology.

[44]  K. Suzuki,et al.  A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle , 1992, Molecular and cellular biology.

[45]  K. Suzuki,et al.  Purification and characterization of protein kinase C epsilon from rabbit brain. , 1992, Biochemistry.

[46]  J. Sellers,et al.  Catalytic fragment of protein kinase C exhibits altered substrate specificity toward smooth muscle myosin light chain , 1991, FEBS letters.

[47]  T. Kuroki,et al.  Structure and properties of a ubiquitously expressed protein kinase C, nPKCδ , 1991 .

[48]  P. Cook,et al.  Effect of phorbol esters on cytosolic protein kinase C content and activity in the human monoblastoid U937 cell. , 1991, The Journal of biological chemistry.

[49]  B. Horecker,et al.  Identification of the proteolytically activated form of protein kinase C in stimulated human neutrophils. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Altman,et al.  Selective post-transcriptional down-regulation of protein kinase C isoenzymes in leukemic T cells chronically treated with phorbol ester. , 1990, The Journal of biological chemistry.

[51]  Y. Nishizuka,et al.  Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). , 1989, The Journal of biological chemistry.

[52]  S. Ohno,et al.  A novel phorbol ester receptor/protein kinase, nPKC, distantly related to the protein kinase C family , 1988, Cell.

[53]  A. W. Murray,et al.  Application of phorbol ester to mouse skin causes a rapid and sustained loss of protein kinase C , 1987, Nature.

[54]  D. K. Ways,et al.  Dissimilar effects of phorbol ester and diacylglycerol derivative on protein kinase activity in the monoblastoid U937 cell. , 1987, Cancer research.

[55]  R. Bell,et al.  The lipid binding, regulatory domain of protein kinase C. A 32-kDa fragment contains the calcium- and phosphatidylserine-dependent phorbol diester binding activity. , 1986, The Journal of biological chemistry.

[56]  F. Huang,et al.  Conversion of protein kinase C from a Ca2+-dependent to an independent form of phorbol ester-binding protein by digestion with trypsin. , 1986, Biochemical and Biophysical Research Communications - BBRC.

[57]  E. Huberman,et al.  Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[58]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[59]  Z. Darżynkiewicz,et al.  Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteases. , 1992, Oncology research.